Vaginal atrophy. Postmenopausal atrophic vaginitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Being Iranian and residing in Rasht Satisfaction with participating in the study Body mass index less than 30 Reading and writing literacy Married and having had sexual activity in the past 6 months Natural menopause Aged 45-60 years Normal pap smear Diagnosis of vaginal atrophy
Exclusion criteria
Exclusion criteria: Using phytoestrogens one month before the start of the study Hormone therapy in the past 6 months before the start of the study Abnormal vaginal bleeding Specific medical conditions Use of specific medications Vaginal infections History of cancer and estrogen-related diseases History of severe anxiety and depression Sensitivity to basil Visit due to complaints of vaginal atrophy and request for treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mental symptoms of vaginal atrophy. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: Vaginal assessment scale.;Vaginal PH. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: PH-indicator strips.;Vaginal maturation index. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: Pathological examination.;Vaginal maturation value. Timepoint: Before the study, and 8 weeks after the intervention. Method of measurement: Pathological examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences